Be Well Clinical StudiesBe Well Clinical Studies Facebook ad: “Weight Loss Study”
Ran for 36 days, from March 16 to April 21, 2026, the last day Crush saw it.
Run by Be Well Clinical Studies on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1465529118434004
- Platforms
- Facebook, Instagram, Audience Network and Messenger
- Relaunches
- 0
Ad text
Weight Loss Clinical Trial for Wegovy and Zepbound Users Be Well Clinical Studies is conducting a clinical research study for weight management and seeing positive results. Qualified participants will receive all study-related care and investigational medication at no cost. Participants can also receive reimbursement for gym memberships during the study, nutritional counseling and daily meal delivery at no cost. To Qualify: - Age: 18 to 79 - Have been on Wegovy at 1.7mg or 2.4mg or Zepbound at 10mg or 15mg for weight loss at stable dose for at least 3 months - Are responding well and tolerating the semaglutide or tirzepatide treatment - In generally stable health Reimbursement up to $5,000 is available for study related time and travel.
Where the ad sends people
Weight Loss Study
